Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Ovid Therapeutics Inc. has filed 531 SEC EDGAR filings since 18 Mar 2015

SEC filing history

Showing 26-50 of 531 matching filings.

Per page
25
Current page
2
ARS File 001-38085

ARS

Filing date
27 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38085

DEF 14A

Filing date
27 Apr 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
424B3 File 333-295218

424B3

Filing date
27 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-295218

EFFECT filing

Filing date
24 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
23 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-295218

UPLOAD filing

Filing date
23 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Apr 2026
Reporting date
07 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Apr 2026
Reporting date
07 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Apr 2026
Reporting date
07 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Mar 2026
Reporting date
23 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Mar 2026
Reporting date
23 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Mar 2026
Reporting date
26 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Mar 2026
Reporting date
26 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Mar 2026
Reporting date
26 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Mar 2026
Reporting date
26 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Mar 2026
Reporting date
26 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Mar 2026
Reporting date
26 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Mar 2026
Reporting date
23 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90350

SCHEDULE 13G filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .